Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013

 Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First
                Quarter 2013 Financial Results On May 2, 2013

PR Newswire

SAN DIEGO, April 25, 2013

SAN DIEGO, April 25, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc.
(NASDAQ: CADX), a biopharmaceutical company focused on acquiring,
in-licensing, developing and commercializing proprietary products principally
for use in the hospital setting, today announced that it will release its
first quarter ended March 31, 2013 financial results on Thursday, May 2, 2013.

Cadence management will host a conference call and live webcast to discuss the
financial results on Thursday, May 2, 2013 at 1:30pm Pacific Time (4:30pm
Eastern Time). Interested investors may participate in the conference call by
dialing (877) 303-9145 (domestic) or (760) 536-5203 (international). To
access the webcast, please visit the company's website at www.cadencepharm.com
and go to the Investor Relations page. A replay of the webcast will be
available approximately two hours after the call and remain available on the
company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring,
in-licensing, developing and commercializing proprietary products principally
for use in the hospital setting. The current version of Cadence
Pharmaceuticals' corporate overview may be viewed on the "Investors" page of
www.cadencepharm.com, under "Events and Presentations."

Contacts: William R. LaRue
                 SVP & Chief Financial Officer
                 Cadence Pharmaceuticals, Inc.
                 858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.

Website: http://www.cadencepharm.com
 
Press spacebar to pause and continue. Press esc to stop.